Warning: The NCBI web site requires JavaScript to function. more...
Hormonal control of p53 and chemoprevention.
Jerry DJ, Minter LM, Becker KA, Blackburn AC.
Breast Cancer Res. 2002;4(3):91-4. Epub 2002 Mar 26. Review.
Related citations
Mice expressing a mammary gland-specific R270H mutation in the p53 tumor suppressor gene mimic human breast cancer development.
Wijnhoven SW, Zwart E, Speksnijder EN, Beems RB, Olive KP, Tuveson DA, Jonkers J, Schaap MM, van den Berg J, Jacks T, van Steeg H, de Vries A.
Cancer Res. 2005 Sep 15;65(18):8166-73.
Hormonal approach to breast cancer prevention.
Russo IH, Russo J.
J Cell Biochem Suppl. 2000;34:1-6. Review.
Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M, Zúbor P, Stanclová A, Dussan CA, Bohusová T, Galo S, Dobrota D, Kajo K, Péc M, Racay P.
Neoplasma. 2007;54(2):155-61.
Disruption of estrogen receptor alpha-p53 interaction in breast tumors: a novel mechanism underlying the anti-tumor effect of radiation therapy.
Liu W, Ip MM, Podgorsak MB, Das GM.
Breast Cancer Res Treat. 2009 May;115(1):43-50. Epub 2008 May 15.
Interaction of Werner and Bloom syndrome genes with p53 in familial breast cancer.
Wirtenberger M, Frank B, Hemminki K, Klaes R, Schmutzler RK, Wappenschmidt B, Meindl A, Kiechle M, Arnold N, Weber BH, Niederacher D, Bartram CR, Burwinkel B.
Carcinogenesis. 2006 Aug;27(8):1655-60. Epub 2006 Feb 25.
Functional polymorphisms, altered gene expression and genetic association link NRH:quinone oxidoreductase 2 to breast cancer with wild-type p53.
Yu KD, Di GH, Yuan WT, Fan L, Wu J, Hu Z, Shen ZZ, Zheng Y, Huang W, Shao ZM.
Hum Mol Genet. 2009 Jul 1;18(13):2502-17. Epub 2009 Apr 7.
Knockout and transgenic mice of Trp53: what have we learned about p53 in breast cancer?
Blackburn AC, Jerry DJ.
Breast Cancer Res. 2002;4(3):101-11. Epub 2002 Apr 18. Review.
Breast cancer: the protective effect of pregnancy.
Medina D.
Clin Cancer Res. 2004 Jan 1;10(1 Pt 2):380S-4S.
Breast cancer risk associated with genotypic polymorphism of the genes involved in the estrogen-receptor-signaling pathway: a multigenic study on cancer susceptibility.
Yu JC, Hsu HM, Chen ST, Hsu GC, Huang CS, Hou MF, Fu YP, Cheng TC, Wu PE, Shen CY.
J Biomed Sci. 2006 May;13(3):419-32. Epub 2006 Feb 25.
Estrogens, regulation of p53 and breast cancer risk: a balancing act.
Jerry DJ, Dunphy KA, Hagen MJ.
Cell Mol Life Sci. 2010 Apr;67(7):1017-23. Review.
Elevated expression of the tumor suppressing protein p53 is associated with the presence of mouse mammary tumor-like env gene sequences (MMTV-like) in human breast cancer.
Lawson JS, Tran DD, Ford C, Rawlinson WD.
Breast Cancer Res Treat. 2004 Sep;87(1):13-7.
Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States).
Grabrick DM, Vierkant RA, Anderson KE, Cerhan JR, Anderson VE, Seller TA.
Cancer Causes Control. 2002 May;13(4):333-41.
The prevention of hereditary breast cancer.
Rodriquez E, Domchek SM.
Semin Oncol. 2007 Oct;34(5):401-5. Review.
Reproductive factors in relation to breast cancer characterized by p53 protein expression (United States).
Furberg H, Millikan RC, Geradts J, Gammon MD, Dressler LG, Ambrosone CB, Newman B.
Cancer Causes Control. 2003 Sep;14(7):609-18.
The role of endogenous hormones in the etiology and prevention of breast cancer: the epidemiological evidence.
Muti P.
Ann N Y Acad Sci. 2004 Dec;1028:273-82. Review.
Association of breast cancer outcome with status of p53 and MDM2 SNP309.
Boersma BJ, Howe TM, Goodman JE, Yfantis HG, Lee DH, Chanock SJ, Ambs S.
J Natl Cancer Inst. 2006 Jul 5;98(13):911-9.
Breast cancer susceptibility testing: past, present and future.
Goldberg JI, Borgen PI.
Expert Rev Anticancer Ther. 2006 Aug;6(8):1205-14. Review.
Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
Sprague BL, Trentham-Dietz A, Garcia-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.
Carcinogenesis. 2007 Aug;28(8):1680-6. Epub 2007 Apr 21.
[Breast cancer prevention: from chemoprevention to prophylactic surgery].
Morcel K, Rouquette S, Dugast C, Bendavid C, Audrain O, Levêque J.
J Gynecol Obstet Biol Reprod (Paris). 2008 Nov;37(7):661-71. Epub 2008 Jul 23. Review. French.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on